CAS: 7644-67-9; Diazomycin B

该化合物是一种属于抗生素类别的化学化合物,主要以抗菌特性而闻名,特别是针对某些菌株的抗菌特性; 切除性素展示出一种复杂的分子结构,有助于其行动机制,通常涉及抑制细菌蛋白合成; 这种化合物经常用于研究和药物应用,特别是用于研制新的抗微生物剂; 其溶性和稳定性可因配方和环境条件而异,可影响其效力和临床环境中的应用; 与许多抗生素一样,抗生素的开发潜力是其使用过程中的一个重要考虑因素; 与任何化学物质一样,在与亚切性素合作减少任何潜在的健康风险时,安全和处理预防措施至关重要.

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      海关参考信息

      专利信息


      专利号:US-8734846-B2
      优先权日:2008-06-16
      标 题 :Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles
      发明人:ALI MIR M; HRKACH JEFF; ZALE STEPHEN E; ALVAREZ DE CIENFUEGOS LUIS
      权利人:BIND BIOSCIENCES INC
      摘要:This application provides nanoparticles and methods of making nanoparticles using pre-functionalized poly(ethylene glycol)(also referred to as PEG) as a macroinitiator for the synthesis of diblock copolymers. Ring opening polymerization yields the desired poly(ester)-poly (ethylene glycol)-targeting agent polymer that is used to impart targeting capability to therapeutic nanoparticles. This “polymerization from†approach typically employs precursors of the targeting agent wherein the reactivity of functional groups of the targeting agent is masked using protecting groups. Also described is a “coupling to†that utilized the poly(ethylene glycol)-targeting agent conjugate where the targeting agent remains in its native un-protected form. This method uses “orthogonal†chemistry that exhibit no cross reactivity towards functional groups typically found within targeting agents of interest.

      专利号:US-2008214827-A1
      优先权日:2004-02-03
      标 题:Synthesis of Cyanoimino-Benzoimidazoles
      发明人:GOEHRING R RICHARD; WHITEHEAD JOHN; SHAO BIN
      权利人:EURO CELTIQUE SA
      摘要:Disclosed in certain embodiments is a process for synthesizing a compound of formula (V) and salts thereof.

      专利号:US-2024382626-A1
      优先权日:2023-05-16
      标题 :Irradiation amenable liposomal dye aggregates and methods of synthesis and use thereof
      发明人:PORTER TYRONE; STERN NOAH; TUNNELL JAMES; SHRESTHA BINITA
      权利人:UNIV TEXAS
      摘要:The present invention provides lipid nanoparticles that are amenable to an irradiation at a wavelength at or above 850 nm, have an absorption peak from about 850 to 1100 nm wavelength, and comprise a high transition temperature lipid and a dye (e.g., a J-aggregate of a dye). In some embodiments, the dye (e.g., J-aggregate of the dye) is encapsulated in the lipid nanoparticle. In various embodiments, the present invention also relates to compositions comprising said lipid nanoparticles and methods of generating said lipid nanoparticles and compositions thereof. The present invention further relates to methods relating to the said lipid nanoparticles for imaging, detection, and treatment of diseases or disorders (e.g., phototherapy) in a subject.

      专利号:US-2008281105-A1
      优先权日:2005-01-18
      标题:Novel Quinolinium Salts and Derivatives
      发明人:MACDONALD JAMES E; HYSELL MICHELLE K; YU DEHUA; LI HENRY; WONG-STAAL FLOSSIE
      权利人:IMMUSOL INC
      摘要:The present invention relates generally to the synthesis of novel quinolinium salts and derivative compounds. Such salts and compounds are useful for inhibiting the growth of cancer cells.

      专利号:WO-2011011384-A9
      优先权日:2009-07-20
      标 题 :Synthesis of dendrimer conjugates

      专利号:CA-2555219-A1
      优先权日:2004-02-03
      标 题 :Synthesis of cyanoimino-benzoimidazoles

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: Chang P, Wiernik PH. Phase II study of azotomycin in sarcomas. Cancer Treat Rep. 1977 Dec;61(9):1719-20. Review. Review. Russian.

      合成参考文献


      摘要:National Cancer Institute Report., -(407), 1967
      摘要:Antibiotiki., 18(332), 1973 []
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知